Report Detail
Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4680270 |
- 26 February, 2026 |
- Global |
- 90 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Des-γ-carboxy Prothrombin (DCP) Biomarker market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Des-gamma-carboxy prothrombin (DCP) is an abnormal form of prothrombin, a clotting factor produced by the liver. This test measures the amount of DCP in the blood to help evaluate whether treatment for one type of liver cancer, hepatocellular carcinoma (HCC), is effective.
This report is a detailed and comprehensive analysis for global Des-γ-carboxy Prothrombin (DCP) Biomarker market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Des-γ-carboxy Prothrombin (DCP) Biomarker market size and forecasts, in consumption value ($ Million), 2021-2032
Global Des-γ-carboxy Prothrombin (DCP) Biomarker market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Des-γ-carboxy Prothrombin (DCP) Biomarker market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Des-γ-carboxy Prothrombin (DCP) Biomarker market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Des-γ-carboxy Prothrombin (DCP) Biomarker
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Des-γ-carboxy Prothrombin (DCP) Biomarker market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include FUJIFILM, Eli Lilly and Company, Fujirebio, Roche Diagnostics, Fapon Biotech, Labcorp, Thermo Fisher Scientific, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Des-γ-carboxy Prothrombin (DCP) Biomarker market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Hepatocellular Carcinoma
Anticoagulant Intoxication
Others
Market segment by Application
Hospitals
Clinics
Others
Market segment by players, this report covers
FUJIFILM
Eli Lilly and Company
Fujirebio
Roche Diagnostics
Fapon Biotech
Labcorp
Thermo Fisher Scientific
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Des-γ-carboxy Prothrombin (DCP) Biomarker product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Des-γ-carboxy Prothrombin (DCP) Biomarker, with revenue, gross margin, and global market share of Des-γ-carboxy Prothrombin (DCP) Biomarker from 2021 to 2026.
Chapter 3, the Des-γ-carboxy Prothrombin (DCP) Biomarker competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Des-γ-carboxy Prothrombin (DCP) Biomarker market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Des-γ-carboxy Prothrombin (DCP) Biomarker.
Chapter 13, to describe Des-γ-carboxy Prothrombin (DCP) Biomarker research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Des-γ-carboxy Prothrombin (DCP) Biomarker by Type
- 1.3.1 Overview: Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Type in 2025
- 1.3.3 Hepatocellular Carcinoma
- 1.3.4 Anticoagulant Intoxication
- 1.3.5 Others
- 1.4 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market by Application
- 1.4.1 Overview: Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospitals
- 1.4.3 Clinics
- 1.4.4 Others
- 1.5 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size & Forecast
- 1.6 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast by Region
- 1.6.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region, (2021-2032)
- 1.6.3 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Prospect (2021-2032)
- 1.6.4 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Prospect (2021-2032)
- 1.6.6 South America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 FUJIFILM
- 2.1.1 FUJIFILM Details
- 2.1.2 FUJIFILM Major Business
- 2.1.3 FUJIFILM Des-γ-carboxy Prothrombin (DCP) Biomarker Product and Solutions
- 2.1.4 FUJIFILM Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 FUJIFILM Recent Developments and Future Plans
- 2.2 Eli Lilly and Company
- 2.2.1 Eli Lilly and Company Details
- 2.2.2 Eli Lilly and Company Major Business
- 2.2.3 Eli Lilly and Company Des-γ-carboxy Prothrombin (DCP) Biomarker Product and Solutions
- 2.2.4 Eli Lilly and Company Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Eli Lilly and Company Recent Developments and Future Plans
- 2.3 Fujirebio
- 2.3.1 Fujirebio Details
- 2.3.2 Fujirebio Major Business
- 2.3.3 Fujirebio Des-γ-carboxy Prothrombin (DCP) Biomarker Product and Solutions
- 2.3.4 Fujirebio Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Fujirebio Recent Developments and Future Plans
- 2.4 Roche Diagnostics
- 2.4.1 Roche Diagnostics Details
- 2.4.2 Roche Diagnostics Major Business
- 2.4.3 Roche Diagnostics Des-γ-carboxy Prothrombin (DCP) Biomarker Product and Solutions
- 2.4.4 Roche Diagnostics Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Roche Diagnostics Recent Developments and Future Plans
- 2.5 Fapon Biotech
- 2.5.1 Fapon Biotech Details
- 2.5.2 Fapon Biotech Major Business
- 2.5.3 Fapon Biotech Des-γ-carboxy Prothrombin (DCP) Biomarker Product and Solutions
- 2.5.4 Fapon Biotech Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Fapon Biotech Recent Developments and Future Plans
- 2.6 Labcorp
- 2.6.1 Labcorp Details
- 2.6.2 Labcorp Major Business
- 2.6.3 Labcorp Des-γ-carboxy Prothrombin (DCP) Biomarker Product and Solutions
- 2.6.4 Labcorp Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Labcorp Recent Developments and Future Plans
- 2.7 Thermo Fisher Scientific
- 2.7.1 Thermo Fisher Scientific Details
- 2.7.2 Thermo Fisher Scientific Major Business
- 2.7.3 Thermo Fisher Scientific Des-γ-carboxy Prothrombin (DCP) Biomarker Product and Solutions
- 2.7.4 Thermo Fisher Scientific Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Thermo Fisher Scientific Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of Des-γ-carboxy Prothrombin (DCP) Biomarker by Company Revenue
- 3.2.2 Top 3 Des-γ-carboxy Prothrombin (DCP) Biomarker Players Market Share in 2025
- 3.2.3 Top 6 Des-γ-carboxy Prothrombin (DCP) Biomarker Players Market Share in 2025
- 3.3 Des-γ-carboxy Prothrombin (DCP) Biomarker Market: Overall Company Footprint Analysis
- 3.3.1 Des-γ-carboxy Prothrombin (DCP) Biomarker Market: Region Footprint
- 3.3.2 Des-γ-carboxy Prothrombin (DCP) Biomarker Market: Company Product Type Footprint
- 3.3.3 Des-γ-carboxy Prothrombin (DCP) Biomarker Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value Market Share by Application (2021-2026)
- 5.2 Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2032)
- 6.2 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Application (2021-2032)
- 6.3 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country
- 6.3.1 North America Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2021-2032)
- 6.3.2 United States Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 6.3.3 Canada Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 6.3.4 Mexico Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2032)
- 7.2 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2032)
- 7.3 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country
- 7.3.1 Europe Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2021-2032)
- 7.3.2 Germany Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 7.3.3 France Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 7.3.5 Russia Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 7.3.6 Italy Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Region
- 8.3.1 Asia-Pacific Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Region (2021-2032)
- 8.3.2 China Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 8.3.3 Japan Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 8.3.4 South Korea Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 8.3.5 India Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 8.3.7 Australia Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2032)
- 9.2 South America Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2032)
- 9.3 South America Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country
- 9.3.1 South America Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2021-2032)
- 9.3.2 Brazil Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 9.3.3 Argentina Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size by Country
- 10.3.1 Middle East & Africa Des-γ-carboxy Prothrombin (DCP) Biomarker Consumption Value by Country (2021-2032)
- 10.3.2 Turkey Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
- 10.3.4 UAE Des-γ-carboxy Prothrombin (DCP) Biomarker Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 Des-γ-carboxy Prothrombin (DCP) Biomarker Market Drivers
- 11.2 Des-γ-carboxy Prothrombin (DCP) Biomarker Market Restraints
- 11.3 Des-γ-carboxy Prothrombin (DCP) Biomarker Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Des-γ-carboxy Prothrombin (DCP) Biomarker Industry Chain
- 12.2 Des-γ-carboxy Prothrombin (DCP) Biomarker Upstream Analysis
- 12.3 Des-γ-carboxy Prothrombin (DCP) Biomarker Midstream Analysis
- 12.4 Des-γ-carboxy Prothrombin (DCP) Biomarker Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Des-γ-carboxy Prothrombin (DCP) Biomarker. Industry analysis & Market Report on Des-γ-carboxy Prothrombin (DCP) Biomarker is a syndicated market report, published as Global Des-γ-carboxy Prothrombin (DCP) Biomarker Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Des-γ-carboxy Prothrombin (DCP) Biomarker market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
